General Information of Drug (ID: DML09OS)

Drug Name
GRL-0667 Drug Info
Synonyms BDBM50007789; CHEMBL1173044; GRM; Q27460878; SCHEMBL7938638
Indication
Disease Entry ICD 11 Status REF
Severe acute respiratory syndrome (SARS) 1D65 Investigative [1]
Therapeutic Class
Antiviral Agents
Cross-matching ID
PubChem CID
46174170
ChEBI ID
CHEBI:149790
TTD Drug ID
DML09OS

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [2]
Thioguanine DM7NKEV Acute lymphocytic leukaemia 2B33.3 Approved [3]
Mercaptopurine DMTM2IK Acute lymphoblastic leukaemia 2A85 Approved [3]
PMID20527968-compound-6577871 DMI30V7 Severe acute respiratory syndrome (SARS) 1D65 Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
SARS-CoV papain-like proteinase (PL-PRO) TTRGHB2 R1AB_CVHSA (819-2740) Inhibitor [1]

References

1 Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biologic... J Med Chem. 2010 Jul 8;53(13):4968-79.
2 Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020 Mar;19(3):149-150.
3 Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res. 2015 Mar;115:9-16.